<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">MSCE</journal-id><journal-title-group><journal-title>Journal of Materials Science and Chemical Engineering</journal-title></journal-title-group><issn pub-type="epub">2327-6045</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/msce.2019.75002</article-id><article-id pub-id-type="publisher-id">MSCE-92543</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Comparison between Differently Synthesized Hydroxyapatite Composites for Orthopedic Applications
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kalinga</surname><given-names>Hapuhinna</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rajitha</surname><given-names>Gunaratne</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jagath</surname><given-names>Pitawala</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Department of Science &amp;amp; Technology, Faculty of Science &amp;amp; Technology, Uva Wellassa University, Badulla, Sri Lanka</addr-line></aff><aff id="aff1"><addr-line>Department of Engineering Technology, Faculty of Technology, University of Sri Jayewardenepura, Nugegoda, Sri Lanka</addr-line></aff><pub-date pub-type="epub"><day>14</day><month>05</month><year>2019</year></pub-date><volume>07</volume><issue>05</issue><fpage>16</fpage><lpage>28</lpage><history><date date-type="received"><day>7,</day>	<month>April</month>	<year>2019</year></date><date date-type="rev-recd"><day>19,</day>	<month>May</month>	<year>2019</year>	</date><date date-type="accepted"><day>22,</day>	<month>May</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Study carried to find out chemical and structural suitability of newly synthesized Eppawala hydroxyapatite composite varieties as bone cement, by comparing and contrasting them with human bone as well as commercially available bone cement, which is currently used in orthopedic surgeries. Commercially available methyl methacrylate (MMA) monomer used to reinforce solid state sintered and sol gel synthesized hydroxyapatite ceramic to prepare its composites as bone cements and their physical and chemical properties including composition, crystallinity, presence of functional groups, thermal stability, surface morphology, and microstructural features were examined compared to human bone. Results show there is a close similarity between synthesized products and human bone while credenting high thermal stability, good crystalline, and porous properties than the commercial product. Finally, study concluded newly synthesized composites can be applied directly as a substitution for commercial bone cement while having different properties from each other.
 
</p></abstract><kwd-group><kwd>Human Bone</kwd><kwd> Hydroxyapatite</kwd><kwd> Methyl Methacrylate</kwd><kwd> Orthopedics</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Hydroxyapatite is widely used as a bioceramic due to its close chemical and structural similarity with human hard tissues. It performs several outstanding properties: biocompatibility, non-inflammatory in nature, osteoconductivity, non-toxicity, bioactivity, etc. [<xref ref-type="bibr" rid="scirp.92543-ref1">1</xref>] - [<xref ref-type="bibr" rid="scirp.92543-ref6">6</xref>] As a result it has a range of biomedical applications mainly in the fields of orthopedics and dentistry [<xref ref-type="bibr" rid="scirp.92543-ref7">7</xref>] - [<xref ref-type="bibr" rid="scirp.92543-ref20">20</xref>] .</p><p>Here in this study we have synthesized hydroxyapatite by converting chloroapatite using sol gel technique—acidified route and solid state sintering method considering its ability to replace chlorine with other groups due to the increase of reactivity as its chlorine positions are under strain in the structural framework [<xref ref-type="bibr" rid="scirp.92543-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref22">22</xref>] . Chloroapatite was collected from Sri Lankan Eppawala apatite deposit, which usually contains 34% - 40% total phosphorus expressed as percentage of phosphorus pentoxide (P<sub>2</sub>O<sub>5</sub>) [<xref ref-type="bibr" rid="scirp.92543-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref25">25</xref>] . Apart from that, for sol gel technique, ethanol and dil. nitric acid were used and for solid state sintering technique calcium hydroxide was used. Further synthesized hydroxyapatite is reinforced with a reactive resin, methyl methacrylate (MMA). It is a methyl ester of methacrylic acid. Polymerized forms of synthetic methacrylate resins used as cements in orthopedic and dentistry applications. Also it is able to fix prosthetic devices to bones and to cement bone to bone in difficult fractures as adhesives [<xref ref-type="bibr" rid="scirp.92543-ref26">26</xref>] .</p><p>Selected commercial product majorly consists of zirconium dioxide and a liquid monomer methyl methacrylate (MMA) is currently used as fast curing bone cement in Sri Lankan government hospitals, which indicates for stable attachment of total or partial joint endoprostheses in bone, filling and stabilization bone defects within the scope of internal fixation treatment or for endoprosthes revision surgery and primary and secondary coverage of skull bone defects. It is prepared directly before use by mixing its powder component with liquid monomer component clinically. As a result ductile dough forms which cure within a few minutes [<xref ref-type="bibr" rid="scirp.92543-ref27">27</xref>] .</p><p>As this study designed only to find out the possibility of substituting newly synthesized ceramic composites into human bone and to compare two different methods for synthesizing the same composite, we have only considered structural suitability of ceramic composite as bone cements.</p></sec><sec id="s2"><title>2. Methodology</title><sec id="s2_1"><title>2.1. Sample Preparation</title><p>Natural raw apatite mineral were collected from the Eppawala apatite site. Then they were sorted as high grade rock phosphate (HERP) by the visual appearance of less coated apatite. After removing mud, collection of Apatite rocks were dried under sunlight, crushed using a jaw crusher (Serial no: 1720011, China) into small crystals/powder, grind further into micron/Nano level HERP powder using a planetary ball mill (XQM-4.0A) and sieved using sieve set (A060_01AC/0219, Scotland). Less than 63 micron range particle size powder were collected and oven dried at a temperature less than 150˚C for 5 hrs to prepare moisture removed HERP powder (MHERP). MHERP was taken as the raw material for synthesizing hydroxyapatite using both methods.</p><p>A sol gel synthesized Eppawala hydroxyapatite (SGHAp) was prepared under sol gel technique acidified route using MHERP, absolute ethanol, and diluted acid as the raw materials, as mentioned in the Equation (1). Mixture of MHERP and dil. acid (1:1 ratio) was stirred well in absolute ethanol medium for 4 - 6 hrs until the formation of gel. Then it was oven dried to a temperature less than 120˚C for 15 hrs and again two stage heat sintering were done starting from 400˚C to 750˚C for 8hrs [<xref ref-type="bibr" rid="scirp.92543-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref22">22</xref>] . Finally the synthesized ceramic powder was mixed with commercial methyl methacrylate (MMA) liquid monomer until a paste forms to prepare sol gel hydroxyapatite composite.</p><disp-formula id="scirp.92543-formula1"><label>(1)</label><graphic position="anchor" xlink:href="//html.scirp.org/file/2-1740686x3.png"  xlink:type="simple"/></disp-formula><p>Solid state sintered composite sample was prepared as mentioned bellow. MHERP powder was added with needed weight of Ca(OH)<sub>2</sub> powder, after well mixing, sieving and high temperature heat treating solid state sintered Eppawala hydroxyapatite powder (SSHAp) was synthesized according to Equation (2) [<xref ref-type="bibr" rid="scirp.92543-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref22">22</xref>] . Then the synthesized ceramic powder was mixed with commercial methyl methacrylate (MMA) liquid monomer, until the ductile dough forms.</p><disp-formula id="scirp.92543-formula2"><label>(2)</label><graphic position="anchor" xlink:href="//html.scirp.org/file/2-1740686x4.png"  xlink:type="simple"/></disp-formula><p>As the third step, commercial cement powder and liquid monomer were mixed together until the ductile dough forms, to obtain its composite.</p></sec><sec id="s2_2"><title>2.2. Sample Characterization</title><p>Before mixing with the liquid monomer, commercial bone cement, and raw Eppawala hydroxyapatite was examined under X-ray fluorescence Spectroscopy (Rigaku XRF Spectrometer) to find out its elementary composition and presence of impurities liquid monomer was examined with Fourier Transform Infrared Spectroscopy (Bruker-Alpha FTIR Spectroscopy) ATR mode to confirm its composition. Then sample mixtures of newly prepared bone cements and the sample mixture of commercial bone cement were characterized using XRD, FTIR, TGA, and SEM with EDS techniques together with the human bone sample. The crystallographic phases of samples were determined by X-ray diffractometer (Rigaku-Ultima. IV diffractometer) in reflection mode with Cu Kα1: 0.154 nm radiation. 1.5˚ min<sup>−1</sup> scanned speed was used to collect data within a 2θ range from 15˚ to 80˚. The presence of functional groups was confirmed by using Fourier Transform Infrared Spectroscopy (Bruker-Alpha FTIR Spectroscopy). The FTIR spectra were obtained over the region 400 - 4000 cm<sup>−1</sup> using KBr pellet technique. The resolution of the spectrometer was 4 cm<sup>−1</sup>. The surface morphology and microstructural features of samples were studied using Hitachi SU6600 Analytical Variable Pressure FE-SEM (Field Emission Scanning Electron Microscope) and Oxford Instruments EDX with AZtec software. Furthermore, Thermogravimetric analysis (TGA) was done using a Thermal Analyzer (SDT Q600) with N environment, 10˚C∙min<sup>−1</sup> heating rate, and 1450˚C maximum temperature to find out the thermal stability of samples.</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><p>Both sol gel synthesized Eppawala hydroxyapatite (SGHAp) and solid state sintered Eppawala hydroxyapatite (SSHAp) powder contain Ca, P and O include in higher weight percentages and Fe, Al and Si as the impurities with hexagonal crystal structure showing a close similarity with mammalian bones and consists of many correlated, microcrystalline structures/particles/spherulites while credenting good thermal stability. Specially, SSHAp powder interprets porous properties and SGHAp powder interprets highly crystalline structure [<xref ref-type="bibr" rid="scirp.92543-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref22">22</xref>] .</p><p>Commercial bone cement sample contains Zr and S in higher amounts and Hf in fewer amounts as mentioned in <xref ref-type="table" rid="table1">Table 1</xref>. When comparing to the literature, there is a difference between commercial bone cement with bone ash meal, as it contains 54.14% CaO, 38.03% P<sub>2</sub>O<sub>5</sub> and 0 to 0.9% Fe<sub>2</sub>O<sub>3</sub>, SiO<sub>2</sub>, Al<sub>2</sub>O<sub>3</sub> [<xref ref-type="bibr" rid="scirp.92543-ref27">27</xref>] and previous research findings show that SSHAp and SGHAp have similarity with bone ash in composition [<xref ref-type="bibr" rid="scirp.92543-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref22">22</xref>] .</p><p>Results of SEM with EDS Analysis for SGHAP with MMA mixture, SSHAP with MMA mixture, commercial bone cement with MMA mixture and human bone are indicated in <xref ref-type="table" rid="table2">Table 2</xref>. According to those results; SGHAp with MMA sample contains O in higher amounts and C, Ca, P, Cl in order with least amount of Fe. SSHAp with MMA sample contains O, Ca in higher amounts and then P, C, Cl in order. Fe also found in very less amount as an impurity. In the commercial product O and C carried in higher amounts and then Ca, Zr, S, and P in order. When consider human bone O presence as the highest amount and then C, Ca, P and Na presence in descending order. Na, Mg, Al, Si, S, Fe presence in very fewer amounts. It performs composition similarity with the mixtures</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> XRF results for commercial bone cement</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Element</th><th align="center" valign="middle" >Spot 1</th><th align="center" valign="middle" >Spot 2</th><th align="center" valign="middle" >Spot 3</th><th align="center" valign="middle" >Spot 4</th><th align="center" valign="middle" >Spot 5</th><th align="center" valign="middle" >Spot 6</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Mass %</td><td align="center" valign="middle" >Mass %</td><td align="center" valign="middle" >Mass %</td><td align="center" valign="middle" >Mass %</td><td align="center" valign="middle" >Mass %</td><td align="center" valign="middle" >Mass %</td></tr><tr><td align="center" valign="middle" >16 S</td><td align="center" valign="middle" >8.84</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >10.32</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >40 Zr</td><td align="center" valign="middle" >87.65</td><td align="center" valign="middle" >96.19</td><td align="center" valign="middle" >96.43</td><td align="center" valign="middle" >86.00</td><td align="center" valign="middle" >96.56</td><td align="center" valign="middle" >96.45</td></tr><tr><td align="center" valign="middle" >72 Hf</td><td align="center" valign="middle" >3.51</td><td align="center" valign="middle" >3.81</td><td align="center" valign="middle" >3.57</td><td align="center" valign="middle" >3.67</td><td align="center" valign="middle" >3.44</td><td align="center" valign="middle" >3.55</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> SEM with EDS results for SSHAp with MMA mixture, SGHAp with MMA mixture, Commercial bone cement with MMA mixture and Human bone</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Element</th><th align="center" valign="middle" >SSHAp with MMA mixture (wt%)</th><th align="center" valign="middle" >SGHAp with MMA mixture (wt%)</th><th align="center" valign="middle" >Commercial product with MMA mixture (wt%)</th><th align="center" valign="middle" >Human bone (wt%)</th></tr></thead><tr><td align="center" valign="middle" >O</td><td align="center" valign="middle" >56.8</td><td align="center" valign="middle" >61.3</td><td align="center" valign="middle" >72.0</td><td align="center" valign="middle" >63.1</td></tr><tr><td align="center" valign="middle" >Ca</td><td align="center" valign="middle" >20.2</td><td align="center" valign="middle" >18.2</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >19.5</td></tr><tr><td align="center" valign="middle" >C</td><td align="center" valign="middle" >14.4</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >26.9</td><td align="center" valign="middle" >17.1</td></tr><tr><td align="center" valign="middle" >P</td><td align="center" valign="middle" >8.3</td><td align="center" valign="middle" >8.5</td><td align="center" valign="middle" >0.03</td><td align="center" valign="middle" >8.9</td></tr><tr><td align="center" valign="middle" >Cl</td><td align="center" valign="middle" >0.8</td><td align="center" valign="middle" >0.6</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Zr</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.9</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Fe</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >0.03</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.03</td></tr><tr><td align="center" valign="middle" >S</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.1</td><td align="center" valign="middle" >0.03</td></tr><tr><td align="center" valign="middle" >Na</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.26</td></tr><tr><td align="center" valign="middle" >Mg</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.13</td></tr></tbody></table></table-wrap><p>of SSHAp with MMA and SGHAp with MMA and among synthesized hydroxyapatite composite varieties Ca amount is higher SSHAp with MMA that may due to the addition of calcium hydroxide at the beginning for preparation of ceramic. These results predict that synthesized hydroxyapatite composites rich with Ca, P similarly to healthy human hard tissues. SGHAp with MMA mixture interprets more similarity to human bone in composition than SSHAp with MMA mixture.</p><p>Considering Figures 1-4; SEM images of all mixtures and human bone show that there are good correlations of particles. SSHAp with MMA mixture and human bone only carried out micropores as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Porosity would be helpful for bone ingrowth as well as for good blood circulation. Presence of some different particles shaped in ball with some rough surface, was found in commercial bone cement mixture which may lead to have higher surface area as mentioned in <xref ref-type="fig" rid="fig2">Figure 2</xref>. According to <xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="fig" rid="fig2">Figure 2</xref> &amp; <xref ref-type="fig" rid="fig4">Figure 4</xref>, some crystalline property can be found in both human bone, SSHAp with MMA and SGHAp with MMA mixtures. Among them crystallinty is higher in SGHAp mixture.</p><p><xref ref-type="fig" rid="fig5">Figure 5</xref> shows the resulted graph for liquid monomer it has coincided with the FTIR characteristic graph for methyl methacrylate (MMA) monomer. It interprets several peaks related to stretching vibrations including a sharp intense</p><p>peak at 1731 cm<sup>−1</sup> related to the presence of ester carbonyl group, broad peak nearly 1150 cm<sup>−1</sup> due to the C-O (ester bond) and a peak nearly 800 cm<sup>−1</sup> is due to the bending of C-H. Also literature shows the broad peak ranging from 3100 - 2900 cm<sup>−1</sup> is owing to the presence of stretching vibration. [<xref ref-type="bibr" rid="scirp.92543-ref28">28</xref>] As shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>, all peaks for phosphate groups in the 560 cm<sup>−1</sup>, 640 cm<sup>−1</sup>, 963 cm<sup>−1</sup>, 1028 cm<sup>−1</sup> and 1110 cm<sup>−1</sup> wave no range and characteristic peak for OH<sup>−</sup>/hydroxyapatite nearly 3572 cm<sup>−1</sup> wave no appeared in the human bone as well as the SSHAp with MMA and SGHAp with MMA mixtures [<xref ref-type="bibr" rid="scirp.92543-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref22">22</xref>] . It confirms that even after the mixing with a monomer, the presence of hydroxyapatite in the SSHAp and SGHAp products. When considering commercial product mixture, it shows peak nearly 3572 cm<sup>−1</sup> wave no range, which may due to the presence of OH<sup>−</sup> group, but that couldn’t be identified as hydroxyapatite characteristic</p><p>peak, as no peaks found related to phosphate groups. Peaks related to MMA can be found within the commercial product, SSHAp and SGHAp mixtures as well.</p><p><xref ref-type="fig" rid="fig7">Figure 7</xref>(a) &amp; <xref ref-type="fig" rid="fig7">Figure 7</xref>(b), explain even after mixing MMA monomer, XRD results of both SSHAp and SGAHAp mixtures contain all characteristic peaks related to the crystallographic phases 002, 210, 211, 112, 300, 202, 310, 222, 213 and 004 of hexagonal hydroxyapatite, which shows similarity to human bone. <xref ref-type="fig" rid="fig7">Figure 7</xref>(c), carries the XRD results for commercial bone cement and it has interpreted all the peaks related to 110, 111, 111, 002, 200, 102, 211, 022, 122, 300, 013, 302, 113 and 222 crystallographic phases of monoclinic zirconium dioxide crystal structure with 84.1% crystallinity. Comparing those results with the literature, it can be confirmed that both human bone and synthesized hydroxyapatite composites interpret structural similarity via consisting hexagonal hydroxyapatite except for commercial product. Among them SGHAp with MMA mixture contains more crystalline properties than SSHAp with MMA mixture, as it contains 96% crystallinity and SGHAp mixture contains 99.41% crystallinity [<xref ref-type="bibr" rid="scirp.92543-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref31">31</xref>] .</p><p>When comparing TGA results for human bone, commercial bone cement with MMA mixture, SSHAp with MMA mixture and SGHAp with MMA mixture according to <xref ref-type="fig" rid="fig8">Figure 8</xref>, human bone, SSHAp and SGHAp mixtures have shown the same pattern of weight loss, which was slightly different from commercial product mixture. At the beginning they show weight losses nearly 100˚C to 400˚C which may associate with the dehydration of samples, following that again samples have reduced their weight nearly 600˚C to 700˚C which may occur due to the gas elimination. Then again from 700˚C up to 1400˚C weight</p><p>losses have occurred due to the incipient transformation of produced hydroxyapatite in β-TCP [<xref ref-type="bibr" rid="scirp.92543-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.92543-ref32">32</xref>] . Therefore, it indicates the formation of hydroxyapatite in products as well as in human bone. Those results confirm the composition similarity of human bone and synthesized composite mixtures, as they were containing hydroxyapatite.</p><p>Also due to the least amount of weight loss in synthesized composite mixtures than human bone and commercial product mixtures, it can be concluded that the synthesized SSHAp with MMA and SGHAp with MMA mixtures perform high thermal stability and good material stability in nature and application.</p><p>Apart from these results, literature have evidenced that, hydroxyapatite in cooperated methyl methacrylate (MMA)/poly methyl methacrylate (PMMA) composites givegood thermal stability as well as having improved mechanical properties such as tensile strength, impact strength, fracture toughness, wear resistance etc. [<xref ref-type="bibr" rid="scirp.92543-ref33">33</xref>] - [<xref ref-type="bibr" rid="scirp.92543-ref38">38</xref>] .</p></sec><sec id="s4"><title>4. Conclusions</title><p>The study concludes that SSHAp with MMA and SGHAp with MMA composites have chemical and structural similarities with human bone and performs high thermal stability and good material stability in nature. Among them, SSHAp with MMA composite has shown more similarity to human bone in composition. SSHAp composite interprets microporous structure with less than 50 micron range particles which may lead to osteoconductive properties and SGHAp composite consists of highly crystalline particles. Therefore, both resulted composites can be used as a direct substitution for bone cement. Also it can be concluded that, when synthesizing composites, the brittleness of hydroxyapatite varieties as ceramics has been reduced by increasing ductile properties via addition of MMA.</p><p>Further aging properties and mechanical properties include tensile and impact strengths of these synthesized hydroxyapatite varieties to be studied in future. Also 3D printing technique will be applied to build implants from these materials.</p></sec><sec id="s5"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s6"><title>Cite this paper</title><p>Hapuhinna, K., Gunaratne, R. and Pitawala, J. (2019) Comparison between Differently Synthesized Hydroxyapatite Composites for Orthopedic Applications. Journal of Materials Science and Chemical Engineering, 7, 16-28. https://doi.org/10.4236/msce.2019.75002</p></sec></body><back><ref-list><title>References</title><ref id="scirp.92543-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Kalita, S.J., Bhardwaj, A. and Bhatt, H.A. (2007) Nanocrystalline Calcium Phosphate Ceramics in Biomedical Engineering. Materials Science and Engineering: C, 27, 441-449. https://doi.org/10.1016/j.msec.2006.05.018</mixed-citation></ref><ref id="scirp.92543-ref2"><label>2</label><mixed-citation publication-type="book" xlink:type="simple">Rivera-Munoz, E.M. (2011) Hydroxyapatite-Based Materials: Synthesis and Characterization. In: Fazel-Rezai, R., Ed., Biomedical Engineering—Frontiers and Challenges, IntechOpen, London, 79-95. https://doi.org/10.5772/19123</mixed-citation></ref><ref id="scirp.92543-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Orlovskii, V.P., Komlev, V.S. and Barinov, S.M. (2002) Hydroxyapatite and Hydroxyapatite-Based Ceramics. Inorganic Materials, 38, 973-984.  
http://www2.chemia.uj.edu.pl/~skorska/Biomaterialy/hap/Orlovskii.pdf</mixed-citation></ref><ref id="scirp.92543-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Mostafa, N.Y. and Brown, P.W. (2007) Computer Simulation of Stoichiometric hydroxyapatite: Structure and Substitutions. Journal of Physics and Chemistry of Solids, 68, 431-437. https://doi.org/10.1016/j.jpcs.2006.12.011</mixed-citation></ref><ref id="scirp.92543-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Teixeira, S., Rodriguez, M.A., Pena, P., De Aza, A.H., De Aza, S., Ferraz, M.P., et al. (2009) Physical Characterization of Hydroxyapatite Porous Scaffolds for Tissue Engineering. Materials Science and Engineering: C, 29, 1510-1514.  
https://doi.org/10.1016/j.msec.2008.09.052</mixed-citation></ref><ref id="scirp.92543-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">FLUIDINOVA (2017) Hydroxyapatite: Properties, Uses and Applications. Zobnenovice Review.  
https://www.fluidinova.com/hydroxyapatite-properties-uses-and-applications</mixed-citation></ref><ref id="scirp.92543-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Guo, L., Huang, M. and Zhang, X. (2003) Effects of Sintering Temperature on Structure of Hydroxyapatite Studied with Rietveld Method. Journal of Materials Science: Materials in Medicine, 14, 817-822.  
https://doi.org/10.1023/A:1025048724330</mixed-citation></ref><ref id="scirp.92543-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Thamaraiselvi, T.V., Prabakaran, K. and Rajeswari, S. (2006) Synthsis of Hydroxyapatite that Mimic Bone Mineralogy. Trends in Biomaterials and Artificial Organs, 19, 81-83.</mixed-citation></ref><ref id="scirp.92543-ref9"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shikhanzadeh</surname><given-names> M. </given-names></name>,<etal>et al</etal>. (<year>1998</year>)<article-title>Direct Formation of Nanophase Hydroxyapatite on Cathodically Polarized Electrodes</article-title><source> Journal of Materials Science: Materials in Medicine</source><volume> 9</volume>,<fpage> 67</fpage>-<lpage>72</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.92543-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">(2017) Case Study: Polymer Matrix Composites in Automobiles.  
https://www.princeton.edu/~ota/disk2/1988/8801/880110.PDF</mixed-citation></ref><ref id="scirp.92543-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">(2017) Innovative Materials for Innovative Automobiles. 
https://www.ceramtec.com/files/ca_innovative_materials_for_innovative_automobiles.pdf</mixed-citation></ref><ref id="scirp.92543-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Hapuhinna, H., Gunaratne, R. and Pitawala, H. (2018) Development of a Biomaterial from Naturally Occurring Chloroapatite Mineral for Biomedical Applications. International Journal of Materials and Metallurgical Engineering, 12, 380-388.</mixed-citation></ref><ref id="scirp.92543-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Wei, G. and Ma, P.X. (2004) Structure and Properties of Nanohydroxyapatite/Polymer Composite Scaffolds for Bone Tissue Engineering. Biomaterials, 25, 4749-4757. https://doi.org/10.1016/j.biomaterials.2003.12.005</mixed-citation></ref><ref id="scirp.92543-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Aza, C.A. (2017) Composites in Automotive Applications: Review on Brake Pads and Discs. http://www.bristol.ac.uk/engineering/media/accis/cdt/news/aza.pdf</mixed-citation></ref><ref id="scirp.92543-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">García, D.B. (2017) Ceramic Matrix Composites-Manufacturing and Applications in the Automotive Industry.  
https://www.bristol.ac.uk/engineering/media/accis/cdt/news/bracho-garcia.pdf</mixed-citation></ref><ref id="scirp.92543-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">(2017) Composite Manufacturing. 
http://www.ae.iitkgp.ernet.in/ebooks/chapter3.html#kproj</mixed-citation></ref><ref id="scirp.92543-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Nayak, A.K. (2010) Hydroxyapatite Synthesis Methodologies: An Overview. International Journal of ChemTech Research, 2, 903-907. 
http://sphinxsai.com/s_v2_n2/CT_V.2No.2/ChemTech_Vol_2No.2_pdf/CT=24%20(903-907).pdf</mixed-citation></ref><ref id="scirp.92543-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Deptula, A., Lada, W., Olezak, T., Borello, A., Avani, C. and Dibartolomea, A. (1992) Preparation of Spherical Powders of Hydroxyapatite by Sol-Gel Processing. Journal of Non-Crystalline Solids, 147-148, 537-541.  
https://doi.org/10.1016/S0022-3093(05)80672-6</mixed-citation></ref><ref id="scirp.92543-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Li, P. and de Groot, K. (1994) Better Bioactive Ceramics through Sol-Gel Process. Journal of Sol-Gel Science and Technology, 2, 797-801.  
https://doi.org/10.1007/BF00486353</mixed-citation></ref><ref id="scirp.92543-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Balamurugan, A., Kannan, S., Selvaraj, V. and Rajeswari, S. (2004) Development and Spectral Characterization of Poly (Methyl Methacrylate)/Hydroxyapatite Composite for Biomedical Applications. Trends in Biomaterials and Artificial Organs, 18, 41-45. http://medind.nic.in/taa/t04/i1/taat04i1p41.pdf</mixed-citation></ref><ref id="scirp.92543-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">(2018) Nano Hydroxyapatite Powder.  
https://www.chromspheres.com/nano-hydroxyapatite-powder</mixed-citation></ref><ref id="scirp.92543-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Hapuhinna, H., Gunaratne, R., Pitawala, H., Wijesekara, K. and Ekanayake, E. (2017) Synthesis and Characterization of Hydroxyapatite from Eppawala Rock Phosphate for Biomedical Applications as a Value Added Product. Tradmed International (International Symposium on Traditional and Complementary Medicine).</mixed-citation></ref><ref id="scirp.92543-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Anon (2017) Eppawala Rock Phosphate Deposit and Processing Plant. Wicky’s Blog. 
https://slminerals.blogspot.com/2015/09/eppawala-rock-phosphate-deposit-and.html</mixed-citation></ref><ref id="scirp.92543-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Gunawardane, R.P. (2003) Industries from Eppawala Phosphate Deposit. Daily News. http://archives.dailynews.lk/2003/03/07/fea13.html</mixed-citation></ref><ref id="scirp.92543-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Ratnayake, S.P. and Navaratna, A.N. (2014) Spectroscopic Determination of Metal Impurities in Commercial Raw Material Fertiliser of Sri Lanka. Ceylon Journal of Science, 18, 27-36. https://www.researchgate.net/</mixed-citation></ref><ref id="scirp.92543-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">National Center for Biotechnology Information (2018) Methyl Methacrylate. PubChem Database. https://pubchem.ncbi.nlm.nih.gov/compound/methylmethacrylate</mixed-citation></ref><ref id="scirp.92543-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">(2018) PALACOS R + G (High Viscosity Bone Cement).  
https://www.heraeus.com/media/media/hme/dochme/productshme/palacosbonecement/rrgmvmvglvlvg/ifu/PALACOSRGIFU.pdf</mixed-citation></ref><ref id="scirp.92543-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">IFKA, T., Palou, M.T. and Bazelová, Z. (2012) The Influence of CaO and P2O5 of Bone Ash upon the Reactivity and the Burnability of Cement Raw Mixtures. Ceramics-Silikáty, 56, 76-84. 
https://www.irsm.cas.cz/materialy/cs_content/2012/Ifka_CS_2012_0000.pdf</mixed-citation></ref><ref id="scirp.92543-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Hapuhinna, H., Gunaratne, R. and Pitawala, H. (2018) Development of a Biomaterial from Naturally Occurring Chloroapatite Mineral for Biomedical Applications. International Journal of Chemical, Materials and Biomolecular Sciences, 11.  
https://doi.org/10.5281/zenodo.1340593</mixed-citation></ref><ref id="scirp.92543-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Okada, M. and Matsumoto, T. (2015) Synthesis and Modification of Apatite Nanoparticles for Use in Dental and Medical Applications. Japanese Dental Science Review, 51, 85-95.  
http://www.sciencedirect.com/science/article/pii/S1882761615000186</mixed-citation></ref><ref id="scirp.92543-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Kumar, S., et al. (2015) Biofunctionalized Nanostructured Zirconia for Biomedical Application: A Smart Approach for Oral Cancer Detection. Advanced Science, 2, 1-9.  
https://www.researchgate.net/publication/277667321_Biofunctionalized_Nanostructured_Zirconia_for_Biomedical_Application_A_Smart_Approach_for_Oral_Cancer_Detection</mixed-citation></ref><ref id="scirp.92543-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Miculescu, F. (2018) Complex Analysis on Heat Treated Human Compact Bones. UPB Scientific Bulletin, Series B: Chemistry and Materials Science, 73, 204-208. 
https://www.researchgate.net/publication/267710992_Complex_analysis_on_heat_treated_human_compact_bones</mixed-citation></ref><ref id="scirp.92543-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Caixeta, A.A.G., Pinheiro, N.R., Gon&amp;#231;alves, S.B. and Machado1, F. (2018) In Situ Formation of Methyl Methacrylate/Hydroxyapatite-Based Polymer Composites through a Sequential Bulk-Suspension Polymerization.  
https://www.alice.cnptia.embrapa.br/bitstream/doc/1005126/1/SilviaBelemNICE20142.pdf</mixed-citation></ref><ref id="scirp.92543-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Chow, W.S., Tay, H.K., Azlan, A. and Mohd-Ishak, Z.A. (2008) Mechanical and Thermal Properties of Hydroxyapatite Filled Poly (Methyl Methacrylate) Composites.  
https://www.researchgate.net/publication/242208553_MECHANICAL_AND_THERMAL_PROPERTIES_OF_HYDROXYAPATITE_FILLED_POLYMETHYL_METHACRYLATE_COMPOSITES</mixed-citation></ref><ref id="scirp.92543-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Moreno, K.J., et al. (2014) Preparation and Performance Evaluation of PMMA/HA Nanocomposite as Bulk Material. Journal of Composite Materials, 49, 1345-1353. 
https://journals.sagepub.com/doi/abs/10.1177/0021998314533713</mixed-citation></ref><ref id="scirp.92543-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Serbetc, K., Korkusuz, F. and Hasirci, N. (2000) Mechanical and Thermal Properties of Hydroxyapatite-Impregnated Bone Cement. Turkish Journal of Medical Sciences, 30, 543-549. 
https://pdfs.semanticscholar.org/c36b/fcfc925f24f5cc995c320843bc7f03887fb3.pdf</mixed-citation></ref><ref id="scirp.92543-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Santos, J.G.F., Pita, V.J.R.R., Melo, P.A., Nele, M. and Pinto, J.C. (2011) Production of Bone Cement Composites: Effect of Fillers, Co-Monomer and Particles Properties. Brazilian Journal of Chemical Engineering, 28, 229-241. 
http://www.scielo.br/scielo.php?script=sci_arttext</mixed-citation></ref><ref id="scirp.92543-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, X., Zhang, Y., Ma, G., Yang, D. and Nie, J. (2015) The Effect of the Prefrozen Process on Properties of a Chitosan/Hydroxyapatite/Poly(Methyl Methacrylate) Composite Prepared by Freeze Drying Method Used for Bone Tissue Engineering. RSC Advances, 5, 79679-79686. 
https://pubs.rsc.org/en/content/articlelanding/2015/ra/c5ra14549j 
https://doi.org/10.1039/C5RA14549J</mixed-citation></ref></ref-list></back></article>